mRNA and the Future of Personalized Medicine, With Andrew Geall and Deborah Barbara
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
mRNA and the Future of Personalized Medicine, With Andrew Geall and Deborah Barbara
-
Narrated by:
-
By:
About this listen
Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.
Mentioned- Sandra Barbosu, “Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry,” (ITIF, November 2024)
- Richard Fleischer, dir. Fantastic Voyage, (20th Century-Fox, 1966).
- Stephen Ezell and Meghan Ostertag, “The Bayh-Dole Act’s Role in Stimulating University-Led Regional Economic Growth,” (ITIF, June 2025)
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.